IP Library Granted Patent US 10,793,837
Granted Patent B2
US 10,793,837 · App. 15/579,751 · Granted Oct 6, 2020

Production of polyunsaturated fatty acids (PUFAs) using a novel modular docosahexaenoic acid (DHA) synthase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,793,837
App. No.
15/579,751
Granted
Oct 6, 2020
Kind
B2
Abstract

This disclosure concerns a novel modular docosahexaenoic acid (DHA) synthase and recombinant host organisms genetically modified with such synthase and one or more accessory proteins that allow for and/or improve the production of PUFAs in the host organism. The disclosure also concerns methods of making and using such organisms as well as products obtained from such organisms.

Claims (15)

1. A recombinant nucleic acid molecule selected from the group consisting of: (a) a nucleic acid molecule comprising a polynucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO: 1; (b) a nucleic acid molecule comprising a polynucleotide sequence encoding a protein with modular docosahexaenoic acid (DHA) synthase activity and having at least 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 1; and (c) a nucleic acid molecule comprising the polynucleotide sequence of SEQ ID NO: 2 encoding the protein of SEQ ID NO: 1, wherein said recombinant nucleic acid molecule is operably linked to a transcription control sequence, and wherein said polynucleotide sequence is heterologous to said transcription control sequence.

2. The recombinant nucleic acid molecule of claim 1 , wherein said protein has modular docosahexaenoic acid (DHA) synthase activity when coexpressed with a 4′-phosphopantetheinyl transferase (PPTase) in a host cell.

3. The recombinant nucleic acid molecule of claim 2 , wherein said 4′-phosphopantetheinyl transferase (PPTase) has the amino acid sequence of SEQ ID NO: 5.

4. A recombinant host cell comprising the recombinant nucleic acid molecule of claim 3 .

5. The recombinant host cell of claim 4 , wherein the recombinant host cell is a microbial cell or a plant cell.

6. A genetically modified organism transformed with a recombinant vector comprising the recombinant nucleic acid molecule of claim 1 to express said protein with modular docosahexaenoic acid (DHA) synthase activity, wherein expression of said recombinant nucleic acid molecule encoding said protein increases docosahexaenoic acid (DHA) content in said genetically modified organism as compared to a control organism of the same species, and wherein the genetically modified organism is a plant or a microorganism.

7. The genetically modified organism of claim 6 , wherein the microorganism is a microalga.

8. The genetically modified organism of claim 6 , wherein the microorganism is a bacterium.

9. The genetically modified organism of claim 7 , wherein the microalga is a Thraustochytrid species.

10. The genetically modified organism of claim 6 , wherein said genetically modified organism is a plant.

11. The genetically modified organism of claim 10 , wherein the plant is soybean or canola.

12. The genetically modified organism of claim 7 , wherein the genetically modified organism further comprises at least one polyunsaturated fatty acid (PUFA) selected from the group consisting of: DPA (C22:5, n-6 or n-3), EPA (C20:5, n-3), ARA (C20:4, n-6), GLA (C18:3, n-6), ALA (C18:3, n-3), and SDA (C18:4, n-3).

13. A method of producing docosahexaenoic acid (DHA) content in an organism, comprising: transforming an organism with a recombinant vector comprising the recombinant nucleic acid molecule of claim 1 , expressing said recombinant nucleic acid molecule in said transformed organism, wherein expression of said recombinant nucleic acid molecule encoding said protein increases docosahexaenoic acid (DHA) content in said transformed organism as compared to a control organism of the same species lacking said recombinant nucleic acid molecule, and wherein the transformed organism is a plant or a microorganism.

14. A method of making a recombinant vector comprising inserting the recombinant nucleic acid molecule of claim 1 into a vector.

15. A method of making a recombinant host cell comprising introducing a recombinant vector comprising the recombinant nucleic acid molecule of claim 1 into a host cell, and wherein the recombinant host cell is a microbial cell or a plant cell.

Assignments (2)
CHANGE OF ASSIGNEE ADDRESS Recorded Sep 12, 2025
From: DSM IP ASSETS B.V.
To: DSM IP ASSETS B.V.
Reel/Frame 072873/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: METZ, JAMES G; WANG, JUN; CHEVREUX, BASTIEN; ZIRKLE, ROSS E; BAYNE, ANNE-CECILE; LIPPMEIER, JAMES CASEY
To: DSM IP ASSETS B.V.
Reel/Frame 044703/0502 →